Biomerica, Inc. (BMRA) vs Mangoceuticals, Inc. (MGRX)
A side-by-side comparison of Biomerica, Inc. and Mangoceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BMRA
Biomerica, Inc.
$2.12HealthcareDelayed quote: Oct 6, 2026, 2:43 PM EDT
MGRX
Mangoceuticals, Inc.
$0.42HealthcareDelayed quote: Oct 6, 2026, 2:49 PM EDT
Total return — BMRA vs MGRX
growth of $100 · dividends reinvested · last 4yBMRA -88.7% (-42.0%/yr)MGRX -99.3% (-71.1%/yr)BMRA compounded faster over this window
Log scale — wide-divergence pair
BMRA MGRX
BMRA vs MGRX: by the numbers
- •MGRX is the larger company ($7M vs $7M market cap).
- •Both run net losses; BMRA's is the smaller (-84.79% vs -4791.48% net margin).
Metrics side by side
Valuation
| Metric | BMRA | MGRX |
|---|---|---|
| P/S ratio | 1.47 | 22.41 |
| P/B ratio | 2.49 | 0.56 |
Profitability
| Metric | BMRA | MGRX |
|---|---|---|
| Gross margin | 8.09% | 54.43% |
| Operating margin | -119.54% | -4200.46% |
| Net margin | -84.79% | -4791.48% |
| ROE | -143.54% | -120.58% |
| ROIC | -117.93% | -102.91% |
Growth (annualized)
| Metric | BMRA | MGRX |
|---|---|---|
| Revenue CAGR (5Y) | -9.17% | N/A |
| Total return CAGR (5Y) | -46.66% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.